This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Biotech

High Hopes for Ketamine Depression Treatments

High Hopes for Ketamine Depression Treatments

Does a recreational drug and horse tranquilizer really have potential as an effective treatment for one of the toughest, and most common, psychiatric illnesses out there?

04/17/14 - 09:45 AM EDT

Biotech Stock Mailbag: NeoStem, Gilead and the Importance of Big-Cap Biotech Earnings

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

04/17/14 - 09:18 AM EDT

St. Jude Medical (STJ) Stock Down Despite Positive Earnings Report

St. Jude Medical (STJ) Stock Down Despite Positive Earnings Report

  • Tickers in this article:
  • STJ

St. Jude Medical (STJ) tumbles in trading despite beating analysts EPS estimates by 1 cent

04/16/14 - 11:42 AM EDT

Article
How Will This Earnings Report Affect Abbot Laboratories (ABT) Stock Today?

How Will This Earnings Report Affect Abbot Laboratories (ABT) Stock Today?

  • Tickers in this article:
  • ABT

Abbot Laboratories (ABT) earnings report beats EPS estimates but falls short on revenue

04/16/14 - 09:53 AM EDT

Article
Will This Coverage Initiation Help Regeneron (REGN) Stock Today?

Will This Coverage Initiation Help Regeneron (REGN) Stock Today?

Regeneron Pharmaceuticals (REGN) had coverage initiated on its shares with a 'buy' rating by analysts at Canaccord Genuity

04/16/14 - 08:43 AM EDT

Article
Anacor Pharma Remains Over-Valued on Development of Inferior Drugs

Anacor Pharma Remains Over-Valued on Development of Inferior Drugs

Investors have yet to fully bake in risks of Anacor's two lead drugs flopping commercially.

04/16/14 - 08:00 AM EDT

Article
Bubble Bursting? Only for Biotech & Internet Stocks

Bubble Bursting? Only for Biotech & Internet Stocks

The recent sluggish performance of U.S. stocks is leading some market watchers to question whether we're witnessing the bursting of an equity bubble.

04/15/14 - 11:48 AM EDT

Article
Johnson & Johnson Beats Earnings and Will Lift Dow, Biotech: StockTwits

Johnson & Johnson Beats Earnings and Will Lift Dow, Biotech: StockTwits

Investors say Johnson & Johnson's earnings beat will take the Dow and the biotech sector higher today.

04/15/14 - 11:04 AM EDT

Article
Capitulation? Or a Bounce to Sell Into Now?

Capitulation? Or a Bounce to Sell Into Now?

Prepare yourself for more downside even if we do bounce this week.

04/14/14 - 11:37 AM EDT

Video
Stocks Open Higher on Citi Surprise, Surging Retail Sales Stocks Open Higher on Citi Surprise, Surging Retail Sales
  • Tickers in this article:
  • C
  • GSK

Stocks opened higher open on Monday, buoyed by better-than-expected earnings from Citigroup, while retail sales jumped 1.1% in March, surpassing economists' expectations.

04/14/14 - 09:53 AM EDT

Article
FDA Approves Novartis' ALK Inhibitor! Maybe...Really Soon?

FDA Approves Novartis' ALK Inhibitor! Maybe...Really Soon?

Someone at Novartis screwed up today by sending out a mass email announcing the FDA approval of a new lung cancer drug ceritinib. Brand name: Zykadia. The only problem is FDA hasn't announced the approval of Zykadia yet.

04/11/14 - 03:07 PM EDT

Article
Oh Biotech, You Are a Cruel Bitch

Oh Biotech, You Are a Cruel Bitch

Wednesday's mini rally was a head fake, leading to more selling Thursday.

04/10/14 - 01:09 PM EDT

Video
Markets Jump on Fed Minutes, Loose Policy Stance Reiterated Markets Jump on Fed Minutes, Loose Policy Stance Reiterated
  • Tickers in this article:
  • DJI
  • IXIC

Biotech and social media stocks continued their rebound after selling off earlier this year, while earnings season was off to a promising start after strong results from bellwether stock Alcoa.

04/09/14 - 04:22 PM EDT

Article
When is a Warrant Not a Warrant? When Northwest Bio is Raising Money.

When is a Warrant Not a Warrant? When Northwest Bio is Raising Money.

  • Tickers in this article:
  • NWBO

An explanation of Northwest Bio's "up to" $32 million financing deal.

04/10/14 - 10:24 AM EDT

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs